Dashboard
Manage Tickers

MGTX MeiraGTx Holdings plc

Nasdaq meiragtx.com


$ 8.24 $ 0.49 (6.32 %)    

Monday, 20-Oct-2025 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 611.86 $ 0.00 (0 %)
DIA $ 467.30 $ 0.00 (0 %)
SPY $ 671.67 $ 0.00 (0 %)
TLT $ 91.69 $ 0.00 (0 %)
GLD $ 389.40 $ 0.00 (0 %)
$ 8.24
$ 7.87
$ 8.50 x 4
$ 8.72 x 15
-- - --
$ 4.55 - $ 8.98
358,145
na
662.89M
$ 1.58
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-13-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-12-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-15-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-14-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-10-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-11-2021 06-30-2021 10-Q
18 05-11-2021 03-31-2021 10-Q
19 03-11-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 03-11-2020 12-31-2019 10-K
24 11-07-2019 09-30-2019 10-Q
25 08-07-2019 06-30-2019 10-Q
26 05-14-2019 03-31-2019 10-Q
27 03-26-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-08-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

chardan-capital-maintains-buy-on-meiragtx-hldgs-maintains-35-price-target
Chardan Capital Maintains Buy on MeiraGTx ...
08/15/2025 11:29:24

Chardan Capital analyst Daniil Gataulin maintains MeiraGTx Hldgs (NASDAQ:MGTX) with a Buy and maintains $35 price target.

meiragtx-hldgs-q2-eps-048-misses-046-estimate-sales-3691m-miss-8003m-estimate
MeiraGTx Hldgs Q2 EPS $(0.48) Misses $(0.4...
08/14/2025 12:06:33

MeiraGTx Hldgs (NASDAQ:MGTX) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0....

coinbase-to-rally-around-17-here-are-10-top-analyst-forecasts-for-wednesday
Coinbase To Rally Around 17%? Here Are 10 ...
05/14/2025 12:01:30

chardan-capital-maintains-buy-on-meiragtx-hldgs-lowers-price-target-to-35
Chardan Capital Maintains Buy on MeiraGTx ...
05/14/2025 11:33:34

Chardan Capital analyst Daniil Gataulin maintains MeiraGTx Hldgs (NASDAQ:MGTX) with a Buy and lowers the price target from $...

meiragtx-hldgs-q1-eps-051-misses-045-estimate-sales-193m-miss-443m-estimate
MeiraGTx Hldgs Q1 EPS $(0.51) Misses $(0.4...
05/13/2025 13:50:32

MeiraGTx Hldgs (NASDAQ:MGTX) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0....

meiragtx-announces-it-has-been-granted-fda-regenerative-medicine-advanced-therapy-designation-for-aav-gad-for-treatment-of-parkinsons-disease
MeiraGTx Announces It Has Been Granted FDA...
05/09/2025 12:04:15

-  This RMAT designation is based on data from 3 clinical studies demonstrating the potential benefit of AAV-GAD as a one-time ...

rbc-capital-maintains-outperform-on-meiragtx-hldgs-raises-price-target-to-13
RBC Capital Maintains Outperform on MeiraG...
03/17/2025 14:23:53

RBC Capital analyst Luca Issi maintains MeiraGTx Hldgs (NASDAQ:MGTX) with a Outperform and raises the price target from $11 ...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
03/13/2025 17:06:33

crude-oil-falls-1-dollar-general-posts-upbeat-sales
Crude Oil Falls 1%; Dollar General Posts U...
03/13/2025 16:25:17

g-iii-apparel-posts-better-than-expected-earnings-joins-ballard-power-systems-dollar-general-and-other-big-stocks-moving-higher-on-thursday
G-III Apparel Posts Better-Than-Expected E...
03/13/2025 14:09:31

meiragtx-collaborates-with-hologen-ai-to-expedite-development-of-parkinsons-candidate-stock-soars
MeiraGTx Collaborates With Hologen AI To E...
03/13/2025 13:51:11

MeiraGTx and Hologen form a neuro-AI drug development joint venture, with up to $430M in funding to advance Parkinson's and...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
03/13/2025 12:09:33

meiragtx-hldgs-fy-2024-gaap-eps-212-misses-189-estimate
MeiraGTx Hldgs FY 2024 GAAP EPS $(2.12) Mi...
03/13/2025 12:04:00

meiragtx-inks-strategic-collaboration-with-hologen-ai-meiragtx-to-receive-200m-in-upfront-cash-consideration
MeiraGTx Inks Strategic Collaboration With...
03/13/2025 11:32:41

MeiraGTx will receive $200 million in upfront cash at closing and MeiraGTx and Hologen are forming a joint venture, called Holo...

chardan-capital-maintains-buy-on-meiragtx-hldgs-maintains-36-price-target
Chardan Capital Maintains Buy on MeiraGTx ...
02/24/2025 11:14:33

Chardan Capital analyst Daniil Gataulin maintains MeiraGTx Hldgs (NASDAQ:MGTX) with a Buy and maintains $36 price target.

meiragtx-reports-publication-of-results-from-first-in-human-interventional-study-to-treat-children-with-aipl1-associated-severe-retinal-dystrophy
MeiraGTx Reports Publication Of Results Fr...
02/21/2025 11:32:09

As disclosed in the paper, 4 out of 4 young children with the AIPL1-related retinal dystrophy, LCA4, benefited substantially fr...

meiragtx-granted-fda-rare-pediatric-disease-designation-for-aav8-rk-retgc-in-leber-congenital-amaurosis-due-to-gucy2d-mutations
MeiraGTx Granted FDA Rare Pediatric Diseas...
01/22/2025 13:31:27

meiragtx-announces-fda-fda-regenerative-medicine-advanced-therapy-designation-for-aav2-haqp1-in-treatment-of-grade-23-radiation-induced-xerostomia
MeiraGTx Announces FDA FDA Regenerative Me...
12/09/2024 13:01:47

chardan-capital-maintains-buy-on-meiragtx-hldgs-maintains-36-price-target
Chardan Capital Maintains Buy on MeiraGTx ...
11/18/2024 22:05:42

Chardan Capital analyst Daniil Gataulin maintains MeiraGTx Hldgs (NASDAQ:MGTX) with a Buy and maintains $36 price target.

rbc-capital-maintains-outperform-on-meiragtx-hldgs-raises-price-target-to-11
RBC Capital Maintains Outperform on MeiraG...
11/14/2024 17:01:13

RBC Capital analyst Luca Issi maintains MeiraGTx Hldgs (NASDAQ:MGTX) with a Outperform and raises the price target from $9 t...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION